Biodesix (BDSX) Gross Profit (2019 - 2026)

Biodesix has reported Gross Profit for 8 years, with the latest figure at $21.3 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 49.77% year-over-year to $21.3 million; the trailing twelve-month figure through Mar 2026 stood at $81.8 million (up 23.25% YoY), and the FY2025 full-year result was $80.9 million, up 26.96% from the prior year.
• Gross Profit for Q1 2026 stood at $21.3 million, down from $26.8 million in the prior quarter.
• The five-year high for Gross Profit was $26.8 million in Q4 2025, with the low at $3.3 million in Q1 2022.
• Historically, Gross Profit has averaged $13.0 million across 5 years, with a median of $12.7 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit slumped 68.89% — and 2024, when it jumped 115.2%.
• Biodesix's Gross Profit stood at $6.3 million in 2022, then jumped by 79.24% to $11.3 million in 2023, then soared by 113.26% to $24.1 million in 2024, then grew by 11.24% to $26.8 million in 2025, then fell by 20.32% to $21.3 million in 2026.
• The last three Gross Profit figures came in at $21.3 million (Q1 2026), $26.8 million (Q4 2025), and $17.7 million (Q3 2025), per Business Quant data.